PBK
NVS icon

Peoples Bank (Kansas)’s Novartis NVS Stock Holding History

Peoples Bank (Kansas)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907K Sell
5,790
-200
-3% -$30K 0.88% 37
2026
Q1 		$915K Sell
5,990
-40
-0.7% -$6.13K 0.92% 35
2025
Q4 		$831K Sell
6,030
-230
-4% -$30.1K 0.84% 38
2025
Q3 		$803K Sell
6,260
-428
-6% -$52.2K 0.8% 43
2025
Q2 		$809K Buy
6,688
+150
+2% +$16.9K 0.54% 59
2025
Q1 		$729K Hold
6,538
– – 0.49% 61
2024
Q4 		$636K Hold
6,538
– – 0.44% 67
2024
Q3 		$752K Sell
6,538
-35
-0.5% -$3.97K 0.5% 60
2024
Q2 		$700K Sell
6,573
-110
-2% -$11K 0.55% 52
2024
Q1 		$646K Sell
6,683
-290
-4% -$29.7K 0.51% 54
2023
Q4 		$704K Sell
6,973
-277
-4% -$26.7K 0.56% 53
2023
Q3 		$738K Buy
+7,250
New +$736K 0.63% 47

Other funds holding NVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Peoples Bank (Kansas)'s NVS Position: Q2 2026 in Review

Peoples Bank (Kansas) reduced its Novartis (NVS) stake by 3.3% in Q2 2026, selling an estimated $30K and leaving 5,790 shares worth $907K. The position accounts for 0.88% of the portfolio, ranked #37.

Peoples Bank (Kansas) first reported a position in NVS in Q3 2023 and has held it in 12 quarters since. The position peaked at $915K in Q1 2026. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Peoples Bank (Kansas) held 5,790 shares of Novartis worth $907K as of Q2 2026.
  • Peoples Bank (Kansas) sold 200 Novartis shares in Q2 2026, an estimated $30K.
  • Novartis made up 0.88% of Peoples Bank (Kansas)'s portfolio in Q2 2026, its #37 holding.
  • Peoples Bank (Kansas) first reported a position in Novartis in Q3 2023 and has held it in 12 quarters since.
  • Peoples Bank (Kansas)'s Novartis position peaked at $915K in Q1 2026.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Peoples Bank (Kansas)'s 13F filing for Q2 2026, filed 10 Jul 2026.